Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01220700
Other study ID # Triclosan
Secondary ID
Status Completed
Phase N/A
First received October 12, 2010
Last updated February 5, 2015
Start date September 2010
Est. completion date January 2015

Study information

Verified date February 2015
Source University of Oulu
Contact n/a
Is FDA regulated No
Health authority Finland: Ethics Committee
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine if suture material coated by antimicrobial agent triclosan would decrease the incidence of surgical site infections (SSIs) in paediatric surgery compared to ordinary sutures.

1500 children (age form 4 weeks to 18 years) coming for general pediatric surgery to the Oulu University Hospital are randomised to have sutures coated with triclosan (Vicryl Plus, Monocryl Plus) or ordinary sutures. The occurrence of SSIs is monitored by email questionnaires to the parents on days 10 and 30. The diagnosis of SSIs are made along CDC criteria.


Description:

We have now (spring 2014) recruited almost 1500 patients to the study. When reviewing the recruited material, we found out that the study suture material has been used in 83% of the recruited patients. The reasons for this have been clinical issue during the operation where melting suture material may not have been needed at all.

We have decided to prolong recruiting so that we would gather the calculated sample size of 1500 of patient with study suture material. This will take 12-18 months (probably till autumn 2015).


Recruitment information / eligibility

Status Completed
Enrollment 1635
Est. completion date January 2015
Est. primary completion date January 2015
Accepts healthy volunteers No
Gender Both
Age group N/A to 18 Years
Eligibility Inclusion Criteria:

- any general surgery during childhood where melting sutures will be used

Exclusion Criteria:

- wound infection as a cause for surgery

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Other:
Triclosane
Triclosane coated suture material
Control
Ordinary suture material

Locations

Country Name City State
Finland Oulu University Hospital/ Paediatric Surgery Oulu

Sponsors (1)

Lead Sponsor Collaborator
University of Oulu

Country where clinical trial is conducted

Finland, 

Outcome

Type Measure Description Time frame Safety issue
Primary occurrence of surgical site infections 30 days Yes
See also
  Status Clinical Trial Phase
Completed NCT02578745 - Prophylactic Incisional Care in Obese Women at Cesarean N/A
Withdrawn NCT00463762 - Cefoperazone/Sulbactam In The Treatment Of Serious Intra-Abdominal And Hepatobiliary Infections. Phase 4
Completed NCT00061633 - Phase 2 Trial of TD 6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI) Phase 2
Terminated NCT00651131 - Cubicin(R) for Complicated Post-surgical Wound Infections Phase 4
Completed NCT01700803 - Povidone Iodine and Cesarean Section Wound Infections Phase 3
Completed NCT01049971 - REDWIL: Reduction of Wound Infections in Laparoscopic Colon Resections by Wound Protectors N/A